Silver Book Fact

Hip fracture prevention in at-risk, postmenopausal women saves $333 million annually.

Lasker Foundation. Exceptional Returns: The economic value of America’s investment in medical research. 2000; https://www.medscape.com/viewarticle/447944

Reference

Title
Exceptional Returns: The economic value of America’s investment in medical research
Publisher
Funding First
Publication Date
2000
Authors
Lasker Foundation
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A study of a number of osteoporosis treatments found cost-effectiveness ratios as low as $55,000 per QALY.  
  • Treatment with bisphosphonates are highly cost-effective in women over the age of 70 with osteoporosis and a previous fracture.  
  • Alendronate, a bisphosphonate, has been shown to increase vertebral bone mineral density (BMD) by as much as 8% over 3-years in postmenopausal women with osteoporosis.  
  • Ibandronate, a bisphosphonate, taken daily has been shown to reduce the risk of new vertebral fractures by around 62%.  
  • A systematic review of osteoporosis therapies found good evidence that many are effective in preventing fractures, but concluded that the data are insufficient to determine if any one therapy is…